The Collier Report of U.S. Government Contracting

Old School Reporting Using Modern Technology

Home
>
Alabama
>
Huntsville
>
Qualitest Pharmaceuticals Incorporated

Qualitest Pharmaceuticals Incorporated

  • Qualitest Pharmaceuticals Incorporated

  • View government funding actions
  • Huntsville, AL 358118216
  • Estimated Number of Employees: 119
  • Estimated Annual Receipts: $153,000,000

Sampling of Federal Government Funding Actions/Set Asides

In order by amount of set aside monies.

  • $70,560 - Monday the 24th of September 2012
    Veterans Affairs Department
    DEPT OF VETERANS AFFAIRS
    SPIRONOLACTONE TABLETS FOR PHARMACEUTICAL REPACKAGING PROGRAM (797-D-9601)
  • $67,200 - Wednesday the 22nd of August 2012
    Veterans Affairs Department
    DEPT OF VETERANS AFFAIRS
    SPIRONOLACTONE TABLETS FOR PHARMACEUTICAL REPACKAGING PROGRAM 797-D-9589
  • $47,040 - Tuesday the 10th of January 2012
    Veterans Affairs Department
    DEPT OF VETERANS AFFAIRS
    SPIRONOLACTONE
  • $47,040 - Wednesday the 9th of May 2012
    Veterans Affairs Department
    DEPT OF VETERANS AFFAIRS
    SPIRONOLACTONE FOR PHARMACEUTICAL REPACKAGING PROGRAM
  • $47,040 - Wednesday the 4th of April 2012
    Veterans Affairs Department
    DEPT OF VETERANS AFFAIRS
    SPIRONOLACTONE
  • $47,040 - Thursday the 8th of December 2011
    Veterans Affairs Department
    DEPT OF VETERANS AFFAIRS
    SPIRONOLACTONE - DELIVERY ORDER
  • $47,040 - Friday the 16th of March 2012
    Veterans Affairs Department
    DEPT OF VETERANS AFFAIRS
    SPIRONOLACTONE
  • $47,040 - Monday the 4th of June 2012
    Veterans Affairs Department
    DEPT OF VETERANS AFFAIRS
    SPIRONOLACTONE FOR PHARMACEUTICAL REPACKAGING PROGRAM 797-D-9571
  • $47,040 - Thursday the 3rd of November 2011
    Veterans Affairs Department
    DEPT OF VETERANS AFFAIRS
    SPIRONOLACTONE
  • $47,040 - Monday the 13th of February 2012
    Veterans Affairs Department
    DEPT OF VETERANS AFFAIRS
    SPIRONOLACTONE

© Copyright 2019
The Collier Report published by 1918 Media LLC.
Information displayed in this dossier has been provided through available open source or public sources. No reliance should be made by readers or Collier Report subscribers. Funding actions are complicated and do not always represent dollar-for-dollar payments to vendors nor do they represent payments in certain instances. Requests for the modification of displayed information may be made to help.desk@1918.media.